NovaBay Pharmaceuticals Inc. is a clinical stage pharmaceutical Company engaged in the discovery and development of innovative product candidates for the treatment or prevention of a range of infections in hospital and non-hospital environments.


Updates from The Motley Fool

Latest updates on NOVABAY PHARMACEUTICALS, INC. from Fool.com.


Stock Performance

NBY vs. S&P 500 | 2 Year Performance
View Interactive NBY Charts
Sponsored by

Key Data Points

Primary metrics and data points about NOVABAY PHARMACEUTICALS, INC..
Current Price: $2.34
Prev Close: $2.29
Open: $2.35
Bid: $2.34
Ask: $2.35
Day's Range: $2.27 - $2.38
52wk Range: $1.62 - $15.00
Volume: 11,448
Avg Vol 47,970
Market Cap: $8.17M
P/E (ttm): -0.39
EPS (ttm): -$5.93
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about NOVABAY PHARMACEUTICALS, INC..
CAPS Rating 1 out of 5
 
16 Outperform
5 Underperform
CAPS All Stars
 
4 Outperform
3 Underperform

How do you think NOVABAY PHARMACEUTICALS, INC. will perform against the market?



You pick for NOVABAY PHARMACEUTICALS, INC. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Ron Najafi, CEO

90% Approve

Based on 9 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for NOVABAY PHARMACEUTICALS, INC..

NovaBay Pharmaceuticals Inc. is a clinical stage pharmaceutical Company engaged in the discovery and development of innovative product candidates for the treatment or prevention of a range of infections in hospital and non-hospital environments.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers